Contract Services Contract Research

Merck Drives New Innovation & Adds Capacity to Advance Next Generation (ADC) Therapies

Merck's unique technology, ChetoSensar™, gives new promise to ADCs by alleviating solubility challenges  - New DOLCORE™ platform inc...

 October 29, 2021 | News

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote G...

 October 28, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

  Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

 October 26, 2021 | News

AstraZeneca launches Clinical Data and Insights division in India

The Clinical Data & Insights team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data expe...

 October 20, 2021 | News

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment ...

 October 13, 2021 | News

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

News Facts:- Fujitsu and the University of Tokyo Hospital validate the effectiveness of proprietary AI technology that uses electrocardiographic data...

 October 11, 2021 | News

CPhI Report predicts record EBITDAs for CDMOs in 2022

Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs in the next 2-3 years, with macro factors significantl...

 September 28, 2021 | News

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

  Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...

 September 21, 2021 | News

Novavax Launches Ph 1 & 2 ,Clinical Trial of Combined COVID-19 and Seasonal Influenza Vaccine

First participants enrolled in Phase 1 clinical trial of NanoFlu combination vaccineTM/NVX–CoV2373 with Matrix-M adjuvantTM Novavax, Inc. (Nasdaq:&n...

 September 11, 2021 | News

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

As a signatory, Sai Life Sciences has committed itself to adopting the Ten Principles of the UNGC on human rights, labour, environment and anti-corruption,...

 August 27, 2021 | News

BioAgilytix to Purchase Australia-based 360biolabs®

BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all sta...

 August 17, 2021 | News

ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App

The initial spark of an idea that would eventually become ClinTex started in 2014, at the DIA Forum in Vienna. By 2018, Clintex was formally working on the...

 August 05, 2021 | News

CliniRx to offer full suite of Rave EDC and CDM services to sponsors

 CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to furt...

 July 30, 2021 | News

Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility

Marker Therapeutics, Inc.  a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapi...

 July 30, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close